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Summary
During the past decade, minimally invasive surgery has become a 
part of almost every surgical field. The gynecologic surgeons were 
among the first to recognize the potentials of laparoscopic appro-
ach for management of various benign gynecologic problems. The 
laparoscopic approach offers several advantages over laparotomy. 
Pelvic and abdominal anatomy appears magnified, allowing precise 
diagnosis and treatment of the disease adjacent to vital organs, blood 
vessels, and nerve structures. Additional benefits of laparoscopic 
approach include minimized bleeding from small vessels afforded by 
pneumoperitoneum, the elimination of large abdominal incision, less 
adhesion formation, early ambulation and faster recovery, shorter 
hospital stay, and less cost to the patient and hospital. Although 
clinical examination and the results of preoperative work-up often 
indicate the benign or malignant nature of the adnexal mass, only 
histology can provide the absolute diagnosis. When malignancy 
is detected, immediate surgical  staging by laparoscopy or by la-
parotomy is indicated. Operative laparoscopy for evaluation and 
management of adnexal masses, when performed by a surgeon 
trained in advanced laparoscopic techniques, is safe and effective 
and associated with less morbidity compared with open techniques. 
[Noriega J, Escobar PF. Anatomical and surgical considerations for 
minimally invasive surgery of adnexal mass lesions. MedUNAB 
2005; 8:151-158].
Key words: Laparoscopy ,ultrasonography, adnexal mass, Doppler, 
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Resumen
Consideraciones anatómicas y quirúrgicas de la cirugía mí-
nimamente invasiva de las masas anexiales. Desde la década 
pasada la cirugía minimamente invasiva  ha llegado a ser parte de 
casi todos los campos quirúrgicos. El ginecólogo estuvo entre los 
primeros en reconocer el potencial del abordaje laparoscopico para 
el manejo de varios problemas ginecológicos benignos. La lapa-
roscopia ofrece varias ventajas sobre la laparotomía. La anatomia 
pelvica y abdominal aparece magnificada permitiendo un diagnostico 
y manejo preciso de la enfermedad adyacente a órganos vitales, 
vasos sanguíneos y estructuras neurales. Beneficios  adicionales de 
la laparoscopia incluyen sangrado mínimo de los pequeños vasos 
ayudado por el pneumoperitoneo, eliminación de grandes incisio-
nes, menos formación de adherencias, deambulacion temprana y 
rápida recuperación, corta estancia hospitalaria y menos costos para 
el paciente y hospital. Aunque el examen clínico y los resultados 
del estudio prequirúrgico frecuentemente indican  la naturaleza 
benigna o maligna de de las masas anexiales, solo la histología 
puede proveer el diagnostico absoluto. Cuando un tumor maligno 
es detectado de inmediato se debe realizar una clasificación del 
estadio por laparoscopia o laparotomía. La laparoscopia operatoria 
para evaluación y manejo de masas anexiales cuando es practicada 
por un cirujano entrenado en cirugía laparoscopica avanzada es 
segura ,efectiva y asociada con menos morbilidad comparada con 
las técnicas abiertas.
Palabras clave: Laparoscopia, ultrasonografia, masa anexial, Do-
ppler, Doppler color, cancer ovárico, ultrasonografia transvaginal.
Javier Noriega Rangel, MD* 
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Introduction
During the last 25 years, the field of gynecologic endoscopy 
has advanced tremendously. Advantages of minimally in-
vasive surgery include, shorter hospitalization, cosmetic 
benefits to the patient, less postoperative complications, 
and improved recovery time.1-4 The proven clinical applica-
tions of minimally access surgery have led to the develop-
ment of more advanced operative laparoscopic techniques 
for a wide spectrum of gynecologic diseases.  One issue of 
great interest and importance is laparoscopic surgery of 
adnexal masses.  The management of preoperative sus-
picious adnexal masses still controversial, their remains 
no clear conclusion regarding the optimal preoperative 
evaluation and form of laparoscopic management in this 
patients. This brief review will try to outline some key 
aspects of minimally invasive surgery for adnexal mass 
lesions.
Anatomical considerations
A thorough knowledge of anatomy is required to un-
derstand the potential therapeutic roles of operative 
laparoscopy in the management of adnexal mass lesions 
as well as its limitations, and complications.  The risk 
of surgical complications is linearly correlated with 
surgical technique, instrumentation, and knowledge of 
relevant anatomy. There are normal variations of pelvic 
and abdominal anatomy.  In order to describe certain 
anatomic relationships in the pelvis and abdominal wall 
at laparoscopy and the effect of body mass index (BMI) 
on those parameters, Nezhat and coauthors5 reported on 
clinical measures of distances from the midline to inferior 
epigastric vessels, ureter and infundibulopelvic ligament 
in 103 patients.
They showed that the right ureter was anatomically sig-
nificantly closer to the infundibulopelvic and uterosacral 
ligaments than the left ureter.  They also showed that 
the right inferior epigastric vessels and umbilical liga-
ment coursed more laterally than did those on the left. 
One finding of great interest and importance is that both 
sets of inferior epigastric vessels, and the left umbilical 
ligament and ureter were significantly more difficult to 
identify in overweight women.5
The proximity of the ureter and major vessels to the 
uterosacral and infundibulopelvic ligaments reaffirms 
the need to identify and dissect these structures during 
surgery for adnexal masses and requires knowledge of 
relevant pelvic sidewall, and retroperitoneal anatomy. The 
retroperitoneal space contains the major neural, vascular, 
and lymphatic supply to the pelvis.  The space is usually 
not affected by adhesions or gynecologic diseases.  It is of 
paramount importance for the minimally invasive surgeon 
to be able of use this plane of dissection when the perito-
neal cavity or sidewall has become obliterated. This can 
be particularly daunting during complex operative lapa-
roscopy since the electronically rendered two-dimensional 
view and the optical element of magnification along with 
the effect of pneumoperitoneum and a steep. Trendelem-
berg position gives pelvic anatomy during laparoscopy a 
different appearance.5
Veress needle and trocars-induced vascular injuries are 
serious complications that occur in 0.2 to 2% of laparo-
scopic surgery.6-9 The superficial and deep inferior epigas-
tria vessels provide the main blood supply to the lower 
abdominal wall.  Both of these vessels are at risk of tracer 
related injuries.  In an interesting anatomical study, El-
Markey and coauthors reported on the micro dissection of 
the inferior epigastria artery, its main branches, and the 
perforator vessels in 20 cadavers. The inferior epigastria 
artery was found to be associated with two veins in 90% of 
the cases.  They also showed that the lateral division of the 
deep inferior epigastria artery and the perforator vessels 
it gives are more dominant than the medial perforators.
During operative laparoscopy is routine to placed trac-
ers lateral to the midline, therefore, increasing the risk 
of vascular injuries. Hard and coauthors retrospectively 
reviewed abdominal computed topographic images of 
21 reproductive-aged women at an academic center to 
determine the location of the inferior epigastria, super-
ficial epigastria, and superficial circumflex iliac arteries 
in relation to the syphilis pubis, the umbilicus, and the 
abdominal midline.  They found that above the syphilis the 
inferior and superficial epigastria arteries were 5.6±1.0 
cm (mean ± standard deviation) and 5.5±2.0 cm from the 
midline, respectively. Although the location of these two 
vessels correlated (r = 0.6, p = 0.02), the mean difference 
in their location was 1.4±1.1 cm. and concluded that when 
laparoscopic landmarks are not visible to guide placement, 
lateral tracers should be placed approximately 8 cm from 
the midline and at least 5 cm above the syphilis to mini-
mize the risk of vessel injury.10
In a more recent prospective clinical descriptive study by 
Quaint et al the location and number of abdominal wall 
vessels visible by Tran illumination were recorded for 68 
patients of various weights undergoing laparoscopy for 
different clinical indications. Superficial abdominal wall 
vessels were located by Tran- illumination in the majority 
of women of normal weight regardless of skin color, it was 
however of less value in overweight and obese women. 
More importantly was the fact that the deep inferior 
epigastria vessels were not effectively located by Tran 
illumination, Quaint and coauthors concluded that other 
techniques should be used to minimize the risk of injury 
to these vessels.11
Recently, Saber and coauthors12 determine the efficacy of 
CT scan in mapping the superior and inferior epigastria 
vessels, relative to landmarks apparent at laparoscopy. 
The authors reviewed abdominal and pelvic CT images of 
100 patients, and determined the location of the superior 
and inferior epigastria vessels from the midline at five 
levels, correlated with each other and with the patient 
age, and body mass index.  The authors concluded that the 
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epigastria vessels are usually located in the area between 
4 and 8 cm from the midline depending on the landmark 
being used for the measurement.
The inferior epigastric vessels are branches of the external 
iliac vessel. They coursed cephalad between the abdominal 
wall peritoneum and the rectus muscles .They are found 
lateral to the obliterate umbilical vessels and medial to 
the deep inguinal ring, which can be identified. Transil-
lumination will not help delineate the inferior epigastric 
vessels. Direct visualization is necessary. There are usu-
ally three vessels; two veins and one artery. In patient 
where the vessels can be visualized, the trocars can be 
placed lateral to the rectus muscle (8 cm from the midline) 
and approximately 4-5 cm above the symphysis  pubis. 
Date from computed tomography have shown that the 
mean distance from the middle to the inferior epigastric 
vessels is 5 cm at 3  and 5.2 cm at 5 cm above the sym-
physis pubis.
The superficial abdominal vessels (superficial epigastric 
vessels and superficial iliac arteries) are branches of 
femoral artery.  At 5 cm above symphysis pubis the su-
perficial epigastric vessels are 5.2 cm from midline and 
the superficial circumflex iliac vessels  are 9.5 cm from 
the midline. These vessels can be transilluminated in thin 
patient. Clearly, both the superficial and inferior epigas-
tria abdominal wall vessels are at risk from tracer related 
injuries in gynecologic surgery.  The superficial vessels 
can be accurately located by Tran illumination; however, 
the inferior epigastria vessels cannot be located using that 
technique. The combination of anatomical landmarks ap-
parent at laparoscopy, awareness of normal anatomical 
variation and thorough knowledge of pelvic anatomy will 
determine the safe zone of entry of the anterior abdominal 
wall (figure 1).
Although, neuropathies are infrequently associated with 
major pelvic surgery, it is important to minimize potential 
nerve injury during lower abdominal tracer placements. 
Knowledge of the variations in the course of the iliohy-
pogastric and ilioinguinal nerves is of practical clinical 
importance. Injury to these nerves is usually herald by 
intense burning pain in the lower abdomen, upper medial 
thigh, and pelvic region, with altered skin sensations in 
these same areas.
Whiteside and coauthors13 dissected eleven fresh frozen 
cadavers and located the entrance and termination 
points of 13 iliohypogastric and 16 ilioinguinal nerves. 
The authors concluded that there is great variation in the 
course of these nerves and surgical incisions or trocars 
placements below the level of the anterior superior iliac 
spine have the potential for ilioinguinal or iliohypogastric 
injury.  Ilioinguinal and iliohypogastric nerve injury is the 
second most common source of post-operative neuropathy 
following major pelvic surgery.  The most common source 
of neuropathy is obturator injury (figures 2 and 3).14 
Figure 1. Relationship of the anterior abdominal wall vessel to 
potential entry sites for trocars.
Figure 2.  Location of inferior epigastric vessels in anterior abdominal 
wall and relationship  with round ligament and obliterated  umbilical 
artery. (Courtesy Dr Tomasso Falcone)
Figure 3 .The auxiliary trocars insertion in the iliac fosse lateral to 
the inferior epigastric vessels. (Courtesy Dr Tomasso Falcone)
154
Med
UNAB Vol. 8 No. 2 - Agosto 2005
As laparoscopy is used increasingly for evaluating complex 
adnexal masses, its potential limitations and complica-
tions must be understood.  It is well known that more 
complex laparoscopic procedures are proportionately 
associated with greater rates of operative complications, 
conversions to laparotomy, and postoperative admissions 
to the hospital.15 Moreover, the risk of complications in-
creases with the level of surgery and decreased with 
surgeon’s experience and expertise.16
Operative techniques
Even though, laparoscopic procedures carry a steep 
learning curve, numerous minimally invasive surgical 
techniques for adnexal mass lesions have been developed 
over the years.  Laparoscopy is a safe approach to adnexal 
masses, and may decrease unnecessary laparotomies, all 
this in well selected patients and in experienced hands. 
It has been shown that the establishment of a comprehen-
sive gynecologic endoscopic hospital privileging program 
is associated with a reduction in rates of excess blood 
loss, operating times and a decreasing trend in visceral 
injuries.18
The operative approach  to the pelvic mass has routinely 
been via laparotomy. This provides for early detection, re-
section, and proper staging, should ovarian cancer found. 
Advancement in laparoscopic diagnosis and management 
have decreased the morbidity of  exploratory  laparotomy 
in some patient; however, controversy  has erupted over 
which patient  are considered appropriate for the proce-
dure. However  most  adnexal masses in premenopausal 
and postmenopausal women are benign. In women  oper-
ated on for presence of pelvic mass various studies have 
reported findings  malignancy in 7% to 13% of premeno-
pausal and 8% to 45% of postmenopausal patients.19 
The incidence of unsuspected ovarian cancer at laparos-
copy has been shown to be only 0.04 %  by Nezhat et al20 
and a 1990 survey of the American Association of Gyne-
cologic Laparoscopist.21
Preoperative evaluation
The patient’s age, the clinical exam, and ultrasound 
findings provide an important information that help 
to determine the operative approach. Postmenopausal 
women should also have serum CA-125 value determined 
(table 1). 
Age. Ovarian cancer  has a bimodal age distribution: the 
very young and very old are much more likely to have 
an ovarian malignancy than those patient  who are of 
reproductive age. Among children  and adolescents  with 
complex adnexal masses, the most common neoplasm is 
a teratoma; the most common malignancy is a dysger-
minoma.
The differential diagnosis for adnexal masses in young 
patients include benign (follicular and corpus luteum 
cysts and teratomas) and malignancy (germ cells and 
stromal) origins. The symptoms associated with this 
masses (i.e., hormonal activity )often are critical to the 
correct diagnosis.  Patients in the reproductive-age group 
are far less likely  to have malignancy,  even with the 
classic findings or complex adnexal masses. Cystic masses 
include tubo-ovarian abscesses, hydrosalpinx, bicornuate 
uterus, bowel, bladder, and pelvic kidneys. Solid masses 
include myomas, appendiceal abscess, abdominal wall 
hematomas, and retroperitoneal tumors. False-positive 
results reduce the specificity and predictive value of any 
diagnostic test. Unfortunately, CA-125, the most sensitive 
marker for  epithelial ovarian malignancy, is elevated in 
may other condition found in premenopausal  patients, 
such as pelvic inflammatory disease (PID), endometriosis, 
uterine myomas, and  pregnancy. Thus, CA-125 has high 
positive and negative value in postmenopausal  patient. 
Postmenopausal patients with adnexal masses are far 
more likely to have a malignancy, either  of ovarian, 
uterine or gastrointestinal  origins.  When presented with 
postmenopausal  patient with adnexal mass, the physi-
cian must include gastrointestinal malignancy, uterine 
malignancy, and metastatic disease to the ovaries in the 
differential diagnosis.    
Clinical examination. Physical examination was the 
¨gold standard ̈ used by barber and grabber  in their land-
mark  paper describing  the postmenopausal  palpable 
ovary.22 The location, consistency, and contour of the mass 
often can be helpful in determining the likely origin of the 
mass.  Adnexal masses that  are fixed, irregular, and firm 
are suggestive of  malignancy. An adnexal mass found 
in the presence of ascites or an upper abdominal mass is 
highly  suspicious  for cancer. A fixed mass may be caused 
by endometriosis  or PID; however; this diagnosis should 
never be presumed in a postmenopausal. Several  others 
caveats also must be considered. The possibility  of  the 
findings being caused by bladder  distension  or stool  must 
be considered. If there is any question, the examination 
should  be repeated (before surgical intervention) after 
empty  the bladder or giving 2-day course of laxatives.
In addition to false-positive findings in the physical exami-
nation, the sensitivity of the pelvic examination itself has 
been called in question. Padilla et al found a sensitivity 
of 15% to 36%  in patient already under general anes-
Table 1.  Patient selection strategies
_________________________________________
- History
- Tumor markers 
- Physical exam
- Menopausal status 
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thesia  who were about  to undergo a surgical procedure. 
The ability to examine an adnexal mass  may be further 
hindered by  a pregnant uterus  or patient discomfort. 
Every experienced clinicians knows that the patient who 
had experienced pain during a previous pelvic examina-
tion will be enable to allow other examiners to perform a 
deep palpation.23
Imaging studies. Ultrasound (US)  evaluation of an 
adnexal masses  continues  to be the most widely used 
method. The examination can either be done transab-
dominally (with a full bladder) or transvaginally, which 
allow probe to be physically closer to the adnexal and does 
not require bladder filling. Occasionally, patient may be 
unable  to tolerate the transvaginal approach, limiting 
the examination.  Transvaginal exam is a able to achieve 
greater resolution and clarity  of image, and thus is pre-
ferred over transabdominal exam.
Adnexal masses can be easily categorized into one of four 
patterns: cystic, multicystic, complex, or solid. These cat-
egories, along with notation regarding the patient’s age 
and sonography criterias are helpful factors in order to 
indicate whether a mass is likely to be malignant or not. 
Sonographic findings of irregular borders, papillations, 
solid areas, thick septa, ascites  or matted bowel raise 
concern regarding the possibility of malignancy. solid 
component within an ovarian mass is reported to be the 
most statistically significant predictor of malignancy.24 
Using ultrasonographic criteria, accurate predictions of 
benign masses were made in 96% of patients.25, 26 Nezhat 
et al20 found that none of the four malignant cysts in their 
series had any ultrasound criteria for malignancy. Lapa-
roscopic diagnosis of adnexal masses that are suspicious 
on ultrasound, however, prevents many laparotomies for 
the treatment of benign masses.
Certain echo patterns are highly characteristic of benign 
pathology, but are not simple cyst. Typical US patterns 
exist that are highly accurate with regard to the final 
pathology such as: endometrioma, cystic teratoma, cyst-
adenoma, adenofibroma as hydrosalpinx, as described 
Guerriero et al.27 Cystic teratomas  usually consist of 
cystic and solid components; the solid component often 
has shadowing below it. The solid component often has 
shadowing represents calcification which is found in 
up 70% of cyst teratomas. Despite the high accuracy of 
these specific US patterns in above diagnoses, there is 
still overlap between these benign situations and frank 
malignancy. For instances, the echo-dense area with 
posterior shadowing  as found in cystic teratoma also 
may occur in the adenofibroma or malignancies, such 
as papillary serous ovarian carcinoma or low malignant 
potential tumors. Granulosa cell tumors may resemble 
endometriomas on two-dimensional (2D) ultrasound. The 
published literature found 2-D transvaginal ultrasound 
to be 85to 100% sensitive for identifying an adnexal mass 
as malignant.28
Doppler can be used to determine the presence and loca-
tion of vascular flow. Masses with central vascular flow 
or vascular flow within excrescences are of concern for 
malignancy. Masses with doppler flow limited to the pe-
riphery are more likely to be benign.  Initial reports using 
pulsed Doppler showed high sensitivity and specificity 
for detection of ovarian cancers, but subsequent studies 
have shown considerable overlap of resistive  index (RI) 
and pulsatility index (PI) ratios in benign and malignant 
masses.29, 30 Whereas RI and PI tend to be lower in ma-
lignant ovarian tumors, these indices cannot reliably dif-
ferentiate benign from malignant masses because some 
benign tumors, inflammatory conditions, and the normal 
corpus luteum may have flow patterns similar to those 
found in ovarian malignancies.31 The theory  said low PI 
and RI would indicate decreased vascular resistance as 
one would expect with neovacularization of malignancies. 
However, the lack  of reproducibility, lack of accuracy, 
and the overlap between benign and malignant masses 
have led several investigators to question the value of 
these types of Doppler measurements.31 For this reason, 
pulsed Doppler cannot be used as an independent indi-
cator of malignancy, but it may provide supplemental 
information that is useful in benign versus malignant 
differentiation.
Several multivariate logistic regression scoring systems 
have been developed  for the evaluation of adnexal masses. 
Some investigators have developed a morphologic scoring 
system to standardize diagnosis of ovarian abnormalities 
(table 2). The scoring system or morphologic index assigns 
numerical scores for various US features, such as size, wall 
thickness (> 3 mm), solid components, and number and 
thickness of septations(> 3 mm). Excellent interobserver 
variability is reported with use of the morphologic index,32 
but Timmerman et al33 found similar interobserver vari-
ability (Cohen´s kappa 0.85) when readers used subjective 
assessment of ovarian morphology (malignancy index: a 
function of CA-125 level, ultrasound scoring system, and 
menopausal status).
A  more recent multivariate logistic regression analysis 
notes  that the most important criteria for predicting ma-
lignancy are the presence of solid component   within the 
central portion of the tumor and the presence of vascular 
Table 2. Scoring system for adnexal masses35
Score          Capsule               Septa           Papillarities        Echogenicity     
1                 < 3mm                 Absent           Absent              Sonolucent 
2                 > 3mm             Thin <3 mm                                Low
3                                         Thick > 3mm                                           
4              Irregular, solid                              <3 mm              With echogenic areas
5               Irregular                                      >3 mm              Nonhomogeneus
                                                                                              solid  
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Table 3.  Probability of disease based upon logistic regres-
sion analysis
                                    Premenopausal adnexal masses 
                              Nonsuspicious                                            Suspicious 
Size               < 10cm               > 10 cm                           < 10 cm         > 10 cm 
Probability
malignancy     < 1%                   2,9%                              36.5%            78.6% 
                                       Postmenopausal adnexal masses
                           CA-125 < 100 U/ml                                    CA-125 > 100 U/ml
                       
                                    Ultrasound                                          Ultrasound 
                      Nonsuspicious     Suspicious          Nonsuspicious         Suspicious  
Probability
malignancy         9.7%                  34,4%                        58%                     87.1% 
flow within the same area. These two criteria combined 
yielded a 92% sensitivity and 94% specificity.34
CA-125. Since the majority of ovarian malignancy are 
epithelial, the most important marker to date has been 
CA-125, an antigenic determinant that is expressed in 
neoplastic, but no normal, ovarian epithelium. Levels be-
low 35 U/mL are associated with benign conditions, but 
sensitivity and specificity vary.  Using a cutoff of 30 U/mL, 
the positive predictive value is 75%,and increase to 93% 
with cutoff of 65U/mL. Only 50% of patients with stage 
I ovarian cancers had elevated CA-125 levels, compared 
with 90% of women with stage II.36
Vasilev37 found that 128 of 132 (97%) patients with pelvic 
masses who had a CA-125 < 35 UI/mL had benign masses. 
Eighty percent of patient over 50 years with elevated CA-
125 had malignant masses. However, in  patient  under 50 
years, 34 of 40 (85%) had benign masses. Endometriosis, fi-
broids, adenomyosis, cystic teratoma, and acute or chronic 
salpingitis may be associated with elevated levels. Due 
to the high false positive rate, the use of CA-125 values 
unnecessary exclude many premenopausal women who 
would benefit from operative laparoscopy.  This is way this 
test for premenopausal women with an adnexal masses 
must be not perform. 80% of patient over age 50 who had 
a CA-125 levels > 35 mcg/mL had malignant masses. For 
this reason some authors find the CA-125 value helpful in 
preoperative evaluation of postmenopausal patient.
Accurate preoperative prediction of malignancy is import 
for patient counseling, as well as for selecting the optimal 
operative approach(laparoscopy versus laparotomy), and 
operative procedure (cystectomy versus oophorectomy)
Lynda et al18 in a very interesting study showed that 
ultrasonographic tumor appearance and size are the 
best predictors of malignancy in premenopausal women, 
whereas CA-125 level and ultrasonographic appearance 
are the best  predictors in postmenopausal women. The 
addition of Doppler sonography for cases in which the 
gray scale  findings are suspicious is not recommended; 
this results in a small improvement in positive predictive 
value at the cost of large decrease in sensitivity. Flinker 
and Jacobs38 found similar findings that Linda`s study 
and gave the same conclusion. In figure 4 is our propousal 
about clinical and surgical approach to adnexal masses 
by laparoscopic surgery.
Clinical outcome 
What are the clinical and survival outcomes associated 
with laparoscopic management of early ovarian cancer 
and adnexal masses though to be benign preoperatively? 
In order to answer this question, Havrilesky and coau-
thors39 evaluated the clinical outcomes of 396 patients 














Figure. 4.  Preoperative evaluation
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masses though to be benign preoperative.  Conversion to 
laparotomy occurred in 25% of the patients as well as mass 
ruptured.  This was associated with mass size and prior 
or concurrent hysterectomy.  Blood loss, length of stay, 
and adverse events were all associated with concurrent 
hysterectomy.  More importantly, malignancy occurred 
in 2% of the patients and laparoscopic management was 
not associated with adverse outcomes
Tumor spill 
The intraoperatve rupture of stage I ovarian carcinomas 
does not seem not to affect prognosis. Stovall et al38 re-
ported the 10 year survival rates for 394 women with 
stage I and stage IIa In the 147  women who had the 
tumors removed with the capsule intact,78% survived 10 
year. For the 47 women who had intraoperative puncture 
of the tumor and the 98 women who had intraoperative 
rupture of the tumor, the 10-year survival was 87% and 
84% respectively. Seventyseven percent of women with 
intact tumors were treated  postoperatively, compared 
with 90% of those with puncture o rupture. No patient 
with well differentiated tumor died, regardless of rupture 
or use of postoperative treatment. The authors concluded 
that neither intraoperative puncture nor rupture of the 
tumor had any impact on survival.  
Conclusion 
Careful patient selection can choose patient who are 
appropriate for management of an adnexal mass via 
operative laparoscopy. The development of sensitive 
tumor markers and transvaginal ultrasound has aided 
the clinician in identifying select patient who can be oper-
ated by laparoscopy. In addition, diagnostic and operative 
laparoscopies are now management options, even in post-
menopausal patient. Proper intraoperative assessment 
and liberal used of rapid frozen section are also important. 
Reported studies show that laparoscopy management can 
be safely performed. Operative laparoscopy for evaluation 
and management of adnexal masses, when performed by 
a surgeon trained in advanced laparoscopic techniques, 
is safe and effective and associated with less morbidity 
compared with open techniques. The short hospital stay 
and rapid return to normal activity benefit patient care. 
However, when invasive cancer found at the  time of 
surgery, the surgeon should be prepared to proceed with 
staging laparotomy for appropriate treatment.    
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